Price Chart

Profile

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology.  Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
URL https://www.biohavenpharma.com
Investor Relations URL https://ir.biohaven.com/
HQ State/Province Connecticut
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Feb. 28, 2025 (est.)
Last Earnings Release Nov. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology.  Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
URL https://www.biohavenpharma.com
Investor Relations URL https://ir.biohaven.com/
HQ State/Province Connecticut
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Feb. 28, 2025 (est.)
Last Earnings Release Nov. 12, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A